These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35720371)

  • 1. P140 Peptide Leads to Clearance of Autoreactive Lymphocytes and Normalizes Immune Response in Lupus-Prone Mice.
    Schall N; Talamini L; Wilhelm M; Jouvin-Marche E; Muller S
    Front Immunol; 2022; 13():904669. PubMed ID: 35720371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.
    Page N; Gros F; Schall N; Décossas M; Bagnard D; Briand JP; Muller S
    Ann Rheum Dis; 2011 May; 70(5):837-43. PubMed ID: 21173017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
    Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
    Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.
    Page N; Schall N; Strub JM; Quinternet M; Chaloin O; Décossas M; Cung MT; Van Dorsselaer A; Briand JP; Muller S
    PLoS One; 2009; 4(4):e5273. PubMed ID: 19390596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression.
    Wilhelm M; Wang F; Schall N; Kleinmann JF; Faludi M; Nashi EP; Sibilia J; Martin T; Schaeffer E; Muller S
    Arthritis Rheumatol; 2018 Jul; 70(7):1077-1088. PubMed ID: 29499102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells.
    Page N; Gros F; Schall N; Briand JP; Muller S
    Autophagy; 2011 May; 7(5):539-40. PubMed ID: 21282971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autophagy, autoimmunity and autoimmune diseases].
    Muller S
    Med Sci (Paris); 2017 Mar; 33(3):319-327. PubMed ID: 28367820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
    Wang F; Tasset I; Cuervo AM; Muller S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resetting the autoreactive immune system with a therapeutic peptide in lupus.
    Schall N; Muller S
    Lupus; 2015 Apr; 24(4-5):412-8. PubMed ID: 25801884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option.
    Bonam SR; Wang F; Muller S
    J Autoimmun; 2018 Nov; 94():16-32. PubMed ID: 30219390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantane-based dendrons for trimerization of the therapeutic P140 peptide.
    Lamanna G; Grillaud M; Macri C; Chaloin O; Muller S; Bianco A
    Biomaterials; 2014 Aug; 35(26):7553-61. PubMed ID: 24889033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of peptide P140 in a mouse periodontitis model.
    Akiyama K; Aung KT; Talamini L; Huck O; Kuboki T; Muller S
    Cell Mol Life Sci; 2022 Sep; 79(10):518. PubMed ID: 36104457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates.
    Bonam SR; Ruff M; Muller S
    Cells; 2019 Aug; 8(8):. PubMed ID: 31394830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
    Monneaux F; Lozano JM; Patarroyo ME; Briand JP; Muller S
    Eur J Immunol; 2003 Feb; 33(2):287-96. PubMed ID: 12548559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.
    Kang HK; Ecklund D; Liu M; Datta SK
    Arthritis Res Ther; 2009; 11(2):R59. PubMed ID: 19405952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide.
    Maueröder C; Schall N; Meyer F; Mahajan A; Garnier B; Hahn J; Kienhöfer D; Hoffmann MH; Muller S
    Front Immunol; 2017; 8():16. PubMed ID: 28191006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
    Mohan C; Adams S; Stanik V; Datta SK
    J Exp Med; 1993 May; 177(5):1367-81. PubMed ID: 8478612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis.
    Bendorius M; Neeli I; Wang F; Bonam SR; Dombi E; Buron N; Borgne-Sanchez A; Poulton J; Radic M; Muller S
    Front Immunol; 2018; 9():2158. PubMed ID: 30319621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive T cells with atypical MHC restriction from MRL-lpr/lpr mice: forbidden clones revisited.
    Naparstek Y; Baur K; Reis MD; Breitman L; Mak TW; Schwartz RS; Madaio MP
    J Mol Cell Immunol; 1988; 4(1):35-43. PubMed ID: 2471535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.